These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31590614)

  • 1. Computationally guided identification of Akt-3, a serine/threonine kinase inhibitors: Insights from homology modelling, structure-based screening, molecular dynamics and quantum mechanical calculations.
    Srivastava S; Mehta P; Sharma O; Sharma M; Malik R
    J Biomol Struct Dyn; 2020 Sep; 38(14):4179-4188. PubMed ID: 31590614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics insights for PI3K-δ inhibition & structure guided identification of novel PI3K-δ inhibitors.
    Srivastava S; Singh Choudhary B; Mehta P; Sukanya ; Sharma M; Malik R
    J Biomol Struct Dyn; 2019 Jun; 37(9):2404-2414. PubMed ID: 30047836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
    Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
    J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT Inhibitors: The Road Ahead to Computational Modeling-Guided Discovery.
    Halder AK; Cordeiro MNDS
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of AKT kinase inhibitors as anticancer agents: structure-based design, docking, and molecular dynamics studies of 2,4,6-trisubstituted pyridines.
    Trejo-Soto PJ; Hernández-Campos A; Romo-Mancillas A; Medina-Franco JL; Castillo R
    J Biomol Struct Dyn; 2018 Feb; 36(2):423-442. PubMed ID: 28150530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of promising molecules against MurG as drug target in multi-drug-resistant-
    Amera GM; Khan RJ; Pathak A; Jha RK; Muthukumaran J; Singh AK
    J Biomol Struct Dyn; 2020 Oct; 38(17):5230-5252. PubMed ID: 31787065
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Eduardo Sanabria-Chanaga E; Betancourt-Conde I; Hernández-Campos A; Téllez-Valencia A; Castillo R
    J Biomol Struct Dyn; 2019 Oct; 37(16):4301-4311. PubMed ID: 30477412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-QSAR-aided design of potent c-Met inhibitors using molecular dynamics simulation and binding free energy calculation.
    Balasubramanian PK; Balupuri A; Bhujbal SP; Cho SJ
    J Biomol Struct Dyn; 2019 May; 37(8):2165-2178. PubMed ID: 30044205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico identification of putative bifunctional Plk1 inhibitors by integrative virtual screening and structural dynamics approach.
    Shafique S; Bibi N; Rashid S
    J Theor Biol; 2016 Jan; 388():72-84. PubMed ID: 26493360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel phytochemical inhibitors targeting monkeypox virus thymidine and serine/threonine kinase: integrating computational modeling and molecular dynamics simulation.
    Patel M; Bazaid AS; Azhar EI; Gattan HS; Binsaleh NK; Patel M; Surti M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):13679-13695. PubMed ID: 36852556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding site identification and role of permanent water molecule of PIM-3 kinase: A molecular dynamics study.
    Ul-Haq Z; Gul S; Usmani S; Wadood A; Khan W
    J Mol Graph Model; 2015 Nov; 62():276-282. PubMed ID: 26529487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
    Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
    Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and identification of putative adenosine kinase inhibitors as potential anti-epileptic agents from structural insights.
    Mehta P; Malik R
    J Biomol Struct Dyn; 2020 Nov; 38(18):5320-5337. PubMed ID: 31779529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling, docking and structure-based virtual screening for new inhibitor identification of
    Panda SK; Saxena S; Guruprasad L
    J Biomol Struct Dyn; 2020 Apr; 38(7):1887-1902. PubMed ID: 31179839
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of potential selective inhibitors for ROCKI and ROCKII isoforms with molecular modeling techniques: structure based docking, ADMET and molecular dynamics simulation.
    Bayel Secinti B; Tatar G; Taskin Tok T
    J Biomol Struct Dyn; 2019 Jun; 37(9):2457-2463. PubMed ID: 30047850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human tau-tubulin kinase 1 inhibitors: an integrated e-pharmacophore-based virtual screening and molecular dynamics simulation.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2020 Feb; 38(3):886-900. PubMed ID: 30829560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.